Allon Therapeutics, Inc. Chosen as "Top 10 Partnering Candidate" and Presenting at Major Partnership Conference
11/17/2009 9:50:59 AM
More...
|
Allon Therapeutics, Inc. Releases Third Quarter Operating Results
11/11/2009 11:17:21 AM
More...
|
Canadian Patent Strengthens IP for Allon Therapeutics, Inc.'s 2nd Technology Platform
10/8/2009 10:07:32 AM
More...
|
Allon Therapeutics, Inc. CEO to Present at Rodman & Renshaw Annual Global Investment Conference
9/9/2009 12:45:33 PM
More...
|
Allon Therapeutics, Inc. CEO to Present at Canaccord Adams Global Growth Conference
8/12/2009 9:16:14 AM
More...
|
Allon Therapeutics, Inc. Releases Second Quarter Operating Results
8/11/2009 10:48:15 AM
More...
|
Allon Therapeutics, Inc. Receives Notice of Allowance From European Patent Office for Lead Compound Davunetide (NAP) as Alzheimer's Treatment
5/28/2009 12:07:41 PM
More...
|
Issued U.S. Patent Strengthens IP for Allon Therapeutics, Inc.'s Technology Platform
4/14/2009 12:59:15 PM
More...
|
Allon Therapeutics, Inc. Reports 2008 Audited Operating Results And Updates 2009 Plans
3/9/2009 1:39:58 PM
More...
|
Allon Therapeutics, Inc. Wins 2009 Best Small Cap IR Award
2/10/2009 9:06:52 AM
More...
|
|